Detailed
Compact
Art
Reverse
October 2, 2019
Stephanie Flanders, head of Bloomberg Economics, returns to bring you another season of on-the-ground insight into the forces driving global growth and jobs today. From the cosmetics maker in California grappling with Donald Trump's tariff war, to the coffee vendor in Argentina burdened by the nation's never-ending crises, Bloomberg's 130-plus economic reporters and economists around the world head into the field to tell these stories. Stephanomics will also look hard at the solutions, in the lead-up to Bloomberg’s second New Economy Forum in Beijing, where a select group of business leaders, politicians and thinkers will gather to chart a better course on trade, global governance, climate and more. Stephanomics will help lead the way for those debates not just with Bloomberg journalists but also discussion and analysis from world-renowned experts into the forces that are moving markets and reshaping the world. The new season of Stephanomics launches Oct. 3.
September 26, 2019
Many antibiotic pills we’ve relied on for decades to treat infections no longer work. It’s a global crisis. Hospitals are increasingly stumped. But where do resistant bugs come from?  In our final episode of this season’s Prognosis, Bloomberg Senior Editor Jason Gale takes us to Copenhagen, Denmark, where one scientist searches for clues in airplane waste from all over the globe. He found killer superbugs thriving in healthy people from countries far and wide. Even in countries where antibiotic use has been strictly controlled, resistant bacteria have made their way to people via the food chain. Yet it’s not too late to turn back 
September 19, 2019
It's no secret that dangerous superbugs are showing up more and more in hospitals around the world. But where do they come from? How do they get into hospitals in the first place? In this episode of Prognosis, Bloomberg's Jason Gale unravels the mystery, taking us on a detective's search for the world's most deadly superbugs as they stealthily sneak into hospitals. And how one hospital has come up with a simple yet virtually foolproof safeguard against spreading those bugs once inside the building. The implications are huge for how hospitals around the world fight back against the spread of killer germs.
September 12, 2019
Joel Grimwood was almost certainly going to die. The pump that kept his failing heart going had become infected, and surgery after surgery had scraped away parts of his chest. Drugs didn’t work because the bacteria were in a slime, impenetrable to antibiotics. What saved his life was a little-known treatment called phage therapy. Popular in the former Soviet Union, they’ve fallen out of favor in the West. The viruses are the natural predator of bacteria, and a small number of scientists are trying to turn them against the threat.
September 5, 2019
Among those most vulnerable to superbug infections are cancer chemotherapy patients. In India, many are dying from bacteria poisoning their blood that even the most potent antibiotics available can't stop. This calamitous scenario portends a global crisis as superbugs spread through international travel and trade.
August 26, 2019
On this new season of Prognosis, we look at the spread of infections that are resistant to antimicrobial medicines. You're probably more likely to have heard of these as superbugs. Their rise has been described as a silent tsunami of catastrophic proportions. We travel to countries on the frontline of the crisis, and explore how hospitals and doctors around the world are fighting back. Prognosis’ new season launches Sept. 5.
July 4, 2019
Chinese consumers, just like Westerners, are lining up for DNA tests. But unlike their American and European counterparts, the Chinese appear to have far fewer qualms about privacy and sharing their data. And what they’re expecting to glean from their genetic information goes far beyond family trees or hints of future disease. From assessing the talents of hours-old infants to making career and life decisions based on DNA tests, the Chinese have fully embraced the genetics boom.
June 20, 2019
Do exercise-tracking apps and gadgets like the Fitbit actually make us healthier? Or do they just create a high-tech, data-centric illusion of control over our weight, sleep and general well-being? Bloomberg's Naomi Kresge loaded up some popular apps to find the answer –- and to see if she could get a better night’s sleep than her husband.
June 6, 2019
By now most of us understand the privacy consequences of all the data we handed over to social media and Internet companies. But what happens to the huge amount of health information we generate from health apps, DNA kits, doctors' visits, blood tests and fitness trackers? Some of it's carefully protected by law. Other data -- including intimate details about our lives -- can be sold to brokers who trade it like a commodity. How worried should we be?
May 23, 2019
On our latest episode of Prognosis, reporter Kristen V. Brown sells her DNA data to the highest bidder. Health data has turned into big business, but Brown quickly realized she wasn’t about to get rich. In exchange for an Amazon gift card or a few shares of marginal value, companies promise to use your data in the quest for better healthcare.
May 9, 2019
On this episode of Prognosis, reporter Michelle Fay Cortez probes one of the more disturbing unintended consequences of the genetic testing revolution. DNA tests have become so prevalent that more and more people are discovering they have rare and potentially dangerous or even lethal genetic mutations. But how accurate are those findings? And what should people and their doctors do about them? Michelle tells the story of one family faced with the decision whether to proceed with life-altering surgeries to avoid facing a cancer diagnoses one day in the future.
April 25, 2019
A century-old quest for family records to unite relatives in heaven has transformed the church into a global leader in genealogy technology. That's paved the way for the success of companies like 23andMe who sell the promise of helping us figure out who are and where we come from.
April 19, 2019
On this new show from Bloomberg, hosts Mike Regan and Sarah Ponczek speak with expert guests each week about the main themes influencing global markets. They explore everything from stocks to bonds to currencies and commodities, and how each asset class affects trading in the others. Whether you’re a financial professional or just a curious retirement saver, What Goes Up keeps you apprised of the latest buzz on Wall Street and what the wildest movements in markets will mean for your investments.
April 11, 2019
On this episode of Prognosis, we'll meet the Bloody Health collective – a group of feminist coders in Berlin who are looking for a safer way to track their periods. Targeted advertising, third-party data sharing and tracking make most menstruation apps just as problematic as they are popular, privacy activists argue. For the women of Bloody Health, the sure way to keep control is to build their own open-source app.
April 5, 2019
The Pay Check is back for a second season! For the next six weeks, we’re going to dig into the number one reason women still make less money than men: Motherhood. Women start their careers earning just about the same as men do, but once they have their first kid, that pay gap grows to a chasm. This season, we’ll show you how this “motherhood penalty” plays out for real women, in real life and how it affects the global economy.
March 28, 2019
On the latest edition of Prognosis, we'll tell you how a simple DNA genealogy test upended the life of a Washington state sheep farmer. Instead of finding out more about the Swedish and Jewish roots she'd heard about, she found that she had an entire family she didn't know about, and a connection to a man with a mysterious and controversial past. These types of genetic surprises are getting more common, and redefining who we call family.
March 21, 2019
Prognosis is back for a second season. Over the next few weeks, we're acknowledging how science and technology are making it easier for us to know pretty much everything there is to know about ourselves: Where we come from. The best time to conceive. What might kill us. And what happens when we start getting all that information, and handing it over to others.
February 8, 2019
The Pay Check is collecting stories for our upcoming season, and we want to hear from you! Did having a kid change your career trajectory or the way you work? If you have anything you want to share, call and leave us a voicemail at (212) 617-0166. Stay tuned for more very soon!
December 24, 2018
Some patients can't wait for pharmaceutical companies to develop drugs. They're pushing the drug industry to make the cures they and their loved ones need. But what's good for patients is also good for pharma's profits, creating a web of murky incentives that makes the issue of high drug costs all the more difficult to parse. In episode 8, Bloomberg's Rebecca Spalding talks to these professional patients about their relationships to the big companies whose therapies they need.
December 17, 2018
Should a patient dying of a disease with no proven cure have the right to try whatever experimental drug they want? A controversial new law signed by President Trump this year says that they should, bypassing the FDA. In episode seven, Bloomberg's Michelle Fay Cortez explores what the new Right To Try law means for desperate patients who want access to experimental treatments. It isn't as simple as it sounds.
December 10, 2018
When you pick up your prescription at the pharmacy, do you ever wonder how that pill made it your way? Who discovered it? Who believed in it when no one else did? Who invested the money to bring it to market? This week on Prognosis, Bloomberg's Rebecca Spalding tells the surprising journey of one life-saving drug, from discovery to market. It's a story about a Nobel Prize winner, cutting edge genetic research, billions of pharmaceutical dollars, and of all things, a worm. What does it tell us about health care in America?
December 3, 2018
Researchers and pharmaceutical companies have poured time and money into developing an effective drug to combat obesity. But time and again, the drugs have failed to deliver. In episode five of Prognosis, Bloomberg's James Paton talks to scientists on the cutting edge of weight-loss research, and the companies that may finally be close to finding a medical solution to the obesity crisis.
November 26, 2018
Eighteen years ago, scientists decoded the human genome. But what was supposed to create an era of new cures didn't work out that way, at least not at first. In episode four of Prognosis, some of the most famous names in genetics explain why it took so long to go from mapping life's code to actually helping people, laying the foundations for technologies on the scientific and ethical cutting edge, like modifying people's genes.
November 19, 2018
In episode three of Prognosis, Kristen V. Brown and Sarah McBride take a trip to Burning Man. They're there to follow Rick Doblin, who has become something of a folk hero for those who believe MDMA—Ecstasy—could be a viable clinical treatment for things like PTSD. But to help push an illegal drug into the mainstream, it takes lots of cash. And to find money for an unconventional treatment, what better place than Burning Man?
November 12, 2018
If you had told people from the 1970s that few decades later the globe would be connected with powerful computers held in the palm of your hand, they could be forgiven for thinking you were seriously deluded. Now, a growing number of scientists are convinced we're on a similar threshold with genetic engineering. Today we'll take you on a tour of a biohacker's DNA experiment to change how frogs—and possibly people—grow muscles. It's an experiment which he insists anyone can try at home. He'll even sell you a kit—frogs included—to do it.
November 5, 2018
More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of the pancreas. Now a group of like-minded do-it-yourselfers have gotten together on the internet and—working outside the purview of organized medicine—have figured out how to link a pump, glucose monitor and smartphone to simulate a functioning pancreas. The results have been spectacularly successful.
October 24, 2018
Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing to catch up. Prognosis explores the leading edge of medical advances, and asks who gets—or should get—access to them. We look at how innovation happens, when it fails, and what it means to the people with a disease trying to feel better, live longer, or avoid death.
    15
    15
      0:00:00 / 0:00:00